Hard To Treat Diseases Incorporated Announces Court's Decision - 7/8/2005 1:23:50 PM
DELRAY BEACH, Fla., Jul 8, 2005 (PRIMEZONE via COMTEX) -- Hard To Treat Diseases, Incorporated (HTTD) (Pink Sheets:HTDS) announces today that the Court has rendered a decision on the trial of the Company's claims.
A complete copy of the Court's Memorandum Opinion can be viewed on the Company's Web site at: www.htdsotc.com. Click on Corporate, then click on Legal.
HTTD's CEO, Colm J. King, states, "The Company has spent a lot of time attempting to secure its assets in litigation. HTTD intends to become a respected biotech with the intense focus of negotiating a deal with a major biotech/drug company and attaining the goals of benefiting patients and HTTD's shareholders, the real owners of the company."
On July 7th the Court's Web site announced:
"DECISION RENDERED: Hard to Treat Diseases, Inc. v. Shinn et al., 04-800010. The court has entered a memorandum opinion with findings of fact and conclusions of law holding that (1) the parties' share exchange agreement did close, (2) a Hawaiian corporation known as Shinn Capital owns the right to market a product called Tubercin, and (3) a Florida corporation known as Hard to Treat Diseases, Inc. (Florida) owns 100% of the assets of two Oklahoma corporations: Hard to Treat Diseases, Inc. (Oklahoma) and T-19, Inc. and, therefore, the Florida corporation is entitled to a money judgment against Dr. Ronald Shinn in the sum of $201,620.01. Copies of the court's opinion may be obtained from the clerk of court."
SOURCE: Hard to Treat Diseases, Inc.
Hard to Treat Diseases, Incorporated
Colm J. King, CEO
(561) 278-7856
www.htdsotc.com
. |
